These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37805275)

  • 1. Surfactant delivery strategies to prevent bronchopulmonary dysplasia.
    Kribs A; Roberts KD; Trevisanuto D; O'Donnell C; Dargaville PA
    Semin Perinatol; 2023 Oct; 47(6):151813. PubMed ID: 37805275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surfactant instillation in spontaneously breathing preterm infants: a systematic review and meta-analysis.
    Rigo V; Lefebvre C; Broux I
    Eur J Pediatr; 2016 Dec; 175(12):1933-1942. PubMed ID: 27678511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surfactant therapy via thin catheter in preterm infants with or at risk of respiratory distress syndrome.
    Abdel-Latif ME; Davis PG; Wheeler KI; De Paoli AG; Dargaville PA
    Cochrane Database Syst Rev; 2021 May; 5(5):CD011672. PubMed ID: 33970483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surfactant delivery via thin catheters: Methods, limitations, and outcomes.
    Devi U; Pandita A
    Pediatr Pulmonol; 2021 Oct; 56(10):3126-3141. PubMed ID: 34379878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung UltrasouNd Guided surfactant therapy in preterm infants: an international multicenter randomized control trial (LUNG study).
    Corsini I; Rodriguez-Fanjul J; Raimondi F; Boni L; Berardi A; Aldecoa-Bilbao V; Alonso-Ojembarrena A; Ancora G; Aversa S; Beghini R; Meseguer NB; Capasso L; Chesi F; Ciarcià M; Concheiro A; Corvaglia L; Ficial B; Filippi L; Carballal JF; Fusco M; Gatto S; Ginovart G; Gregorio-Hernández R; Lista G; Sánchez-Luna M; Martini S; Massenzi L; Miselli F; Mercadante D; Mosca F; Palacio MT; Perri A; Piano F; Prieto MP; Fernandez LR; Risso FM; Savoia M; Staffler A; Vento G; Dani C
    Trials; 2023 Nov; 24(1):706. PubMed ID: 37925512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive Ventilation and Exogenous Surfactant in Times of Ever Decreasing Gestational Age: How Do We Make the Most of These Tools?
    Wright CJ; Glaser K; Speer CP; Härtel C; Roehr CC
    J Pediatr; 2022 Aug; 247():138-146. PubMed ID: 35429507
    [No Abstract]   [Full Text] [Related]  

  • 9. Less invasive surfactant administration: best practices and unanswered questions.
    Herting E; Härtel C; Göpel W
    Curr Opin Pediatr; 2020 Apr; 32(2):228-234. PubMed ID: 32068592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive Support: Does It Really Decrease Bronchopulmonary Dysplasia?
    Wright CJ; Polin RA
    Clin Perinatol; 2016 Dec; 43(4):783-798. PubMed ID: 27837759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surfactant therapy in premature babies: SurE or InSurE.
    Jena SR; Bains HS; Pandita A; Verma A; Gupta V; Kallem VR; Abdullah M; Kawdiya A; On Behalf Of Sure Group
    Pediatr Pulmonol; 2019 Nov; 54(11):1747-1752. PubMed ID: 31424177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous positive airway pressure (CPAP) for respiratory distress in preterm infants.
    Ho JJ; Subramaniam P; Davis PG
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002271. PubMed ID: 33058208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
    Stevens TP; Harrington EW; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory support in preterm infants at birth.
    ;
    Pediatrics; 2014 Jan; 133(1):171-4. PubMed ID: 24379228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surfactant delivery via thin catheter in preterm infants: A systematic review and meta-analysis.
    Yeung TY; Zhou Q; Kanmaz Kutman HG; Pandita A; Philippopoulos E; Jasani B
    PLoS One; 2023; 18(4):e0284792. PubMed ID: 37099568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome.
    Federici C; Fornaro G; Roehr CC
    Eur J Hosp Pharm; 2022 Nov; 29(6):346-352. PubMed ID: 33658228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
    Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
    Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.